Fresenius Kabi recalls sodium acetate injection
Fresenius Kabi USA Monday recalledseven lots of sodium acetate injection after finding particulate matter in sample vials, which could cause infection or other serious adverse events if administered. No adverse events were reported. Hospitals should not use the recalled product, a sodium additive for intravenous fluids.
Related News Articles
Headline
The AHA Aug. 12 provided comments to the Consumer Product Safety Commission on its agenda and priorities for fiscal years 2027 and 2028, specifically…
Headline
The Food and Drug Administration Aug. 3 identified Class I recalls of two convenience kit products. Certain kits by Medline…
Headline
The Food and Drug Administration has identified a recall by Cook Medical of Zenith Alpha 2 Thoracic Endovascular Graft proximal components after Cook Medical…
Headline
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…